Research summary, original research, 2013

Radiation-associated lens opacities in catheterization personnel: results of a survey and direct assessments

Vano E, Kleiman NJ, Duran A, Romano-Miller M, Rehani MM. Journal of vascular and interventional radiology : JVIR. 2013

Read the original paper

In plain language

Among interventional cardiologists, nurses and technicians examined at a cardiology congress, radiation-type posterior lens changes were found in 41-50%, compared with under 10% of unexposed controls. Most affected staff had worked for years without eye protection.

At a glance

Type of study
Original research, Cross-sectional survey
Who was studied
Interventional cardiologists, Nurses, Radiologic technologists, Mixed lab staff
Size
n = 127 exposed catheterization personnel (58 physicians, 69 nurses and technicians)
Summary based on
the abstract

What it found

  • Posterior subcapsular lens changes characteristic of radiation were found in half of interventional cardiologists and 41% of nurses and technicians, versus under 10% of unexposed controls.

    Key figures: 50% of interventional cardiologists; 41% of nurses and technicians; <10% of controls

  • Estimated cumulative eye doses varied widely among exposed staff.

    Key figures: 0.1-18.9 Sv

  • Most lens injuries occurred after several years of work without eye protection.

  • Authors call for improved radiation safety training, eye protection use and occupational dosimetry.

Limits to keep in mind

Convenience sample of congress attendees with lens doses estimated retrospectively from questionnaires and lab measurements rather than personal dosimetry; control group size and country not stated in the abstract.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.